Yalçıntaş Yalçın Mert, Bechelany Mikhael, Karav Sercan
Department of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17000, Turkey.
Institut Européen des Membranes (IEM), Centre National de la Recherche Scientifique (CNRS), École Nationale Supérieure de Chimie de Montpellier (ENSCM), Unité Mixte de Recherche (UMR) 5635, University Montpellier, F-34095 Montpellier, France.
Int J Mol Sci. 2025 Aug 17;26(16):7936. doi: 10.3390/ijms26167936.
Colostrum is a nutrient-rich fluid secreted by mammals shortly after birth, primarily to provide passive immunity and support early immune development in newborns. Among its various sources, bovine colostrum is the most widely used supplement due to its high bioavailability, safety profile, and clinically supported health benefits. Rich in immunoglobulins, lactoferrin, growth factors, and antimicrobial peptides, bovine colostrum exhibits diverse biological activities that extend beyond neonatal health. Recently, the rising prevalence of cancer-driven by environmental stressors such as radiation, processed foods, and chronic inflammation, as well as non-environmental hereditary factors including germline mutations, family history, and epigenetic inheritance-has fueled interest in natural adjunctive therapies. Scientific studies have explored the anticancer potential of bovine colostrum, highlighting its ability to modulate immune responses, inhibit tumor growth, induce apoptosis in cancer cells, and reduce inflammation. Key components including lactoferrin and proline-rich peptides have been identified as contributors to these effects. Additionally, bovine colostrum may help reduce the side effects of standard cancer treatments, such as mouth sores from chemotherapy or weakened immune systems, by helping to heal tissues and boost the body's defenses. While large-scale clinical studies are still needed, current findings suggest that bovine colostrum holds promise as a supportive element in integrative cancer care. In conclusion, bovine colostrum represents a safe, bioactive-rich natural supplement with multifaceted therapeutic potential, particularly in oncology, owing to its key components such as lactoferrin, immunoglobulins, growth factors (e.g., IGF-1, TGF-β), and proline-rich polypeptides (PRPs), which contribute to its immunomodulatory, anti-inflammatory, and potential anticancer effects. Ongoing and future research will be crucial to fully understand its mechanisms of action and establish its role in evidence-based cancer prevention and treatment strategies.
初乳是哺乳动物出生后不久分泌的一种营养丰富的液体,主要用于提供被动免疫并支持新生儿的早期免疫发育。在其各种来源中,牛初乳因其高生物利用度、安全性以及临床支持的健康益处而成为使用最广泛的补充剂。牛初乳富含免疫球蛋白、乳铁蛋白、生长因子和抗菌肽,具有多种生物活性,其作用范围超出了新生儿健康领域。近年来,由辐射、加工食品和慢性炎症等环境应激因素以及种系突变、家族病史和表观遗传等非环境遗传因素驱动的癌症发病率不断上升,激发了人们对天然辅助疗法的兴趣。科学研究探索了牛初乳的抗癌潜力,强调了其调节免疫反应、抑制肿瘤生长、诱导癌细胞凋亡和减轻炎症的能力。已确定乳铁蛋白和富含脯氨酸的肽等关键成分是这些作用的促成因素。此外,牛初乳可能有助于减轻标准癌症治疗的副作用,如化疗引起的口腔溃疡或免疫系统减弱,通过帮助修复组织和增强身体的防御能力。虽然仍需要大规模的临床研究,但目前的研究结果表明,牛初乳有望成为综合癌症护理中的一种支持性元素。总之,牛初乳是一种安全、富含生物活性的天然补充剂,具有多方面的治疗潜力,特别是在肿瘤学领域,这归因于其关键成分,如乳铁蛋白、免疫球蛋白、生长因子(如IGF-1、TGF-β)和富含脯氨酸的多肽(PRPs),这些成分有助于其免疫调节、抗炎和潜在的抗癌作用。正在进行的和未来的研究对于充分了解其作用机制并确定其在循证癌症预防和治疗策略中的作用至关重要。